Challenge: A global manufacturer needed to transition their molecular infectious disease assay from IVDD to IVDR with updated performance claims and expanded intended use.

Solution: MDx implemented a gap assessment, designed a clinical performance strategy compliant with IVDR, and managed sample collection across multiple European countries.

Result: The client achieved IVDR certification with expanded clinical claims, strengthening their market position.